Forecasting and Business Development

Data-Driven Forecasting and Valuation Power Strategic Growth

Elevate Your Strategy with Expert Forecasting and Valuation.

The Dedham Group helps organizations assess market and product opportunities with greater clarity. Whether supporting development, licensing, or product launches, our expertise and strategic approach provide a strong foundation for informed decision-making.

Leveraging advanced methodologies, customized data tools, and proprietary resources from our sister company, Evaluate, we deliver comprehensive, end-to-end forecasting solutions across the asset lifecycle. Each forecast is tailored, fully transparent, and backed by analogue data and primary research.

Partner with us to navigate complexity and maximize potential.

 

Schedule a Meeting

Learn more about the Dedham Group’s Forecasting Expertise:

Our Tailored Services for Success

Landscape & Opportunity Assessment:
Gain a comprehensive understanding of market dynamics, competitive landscapes, and unmet needs to identify the most promising opportunities for growth and differentiation.
Revenue and Demand Forecasting:
Leverage advanced analytics and data-driven insights to create accurate, scenario-based forecasts that guide strategic planning and resource allocation.
M&A and Licensing Strategy:
Develop tailored strategies for mergers, acquisitions, and partnerships, ensuring alignment with corporate goals and maximizing the value of strategic investments.
Cost Assessment and Valuation:
Conduct detailed cost analyses and asset valuations to support financial planning, pricing strategies, and informed decision-making throughout the product lifecycle.

Preferred Industry Partner

Trusted by clients worldwide, we bring over 20 years of expertise, a global presence in 70 countries, and a proven record of over 900 successful projects.

In conjunction with sister company, Evaluate

Leveraging Evaluate’s proprietary resources—we can deliver a seamless, end-to-end forecasting experience across the asset lifecycle.

Data-Driven Excellence

Our bespoke forecasts are meticulously tailored, fully transparent, and rigorously validated using analogue data and primary research.

Additional Resources:

Overcoming Five Major Challenges in Biopharma Forecasting

The phrase “forecasts are always wrong” is a common refrain in the biopharma industry—and for good reason. Over half of pre-commercial assets fail to meet their projected forecasts, yet forecasting remains an indispensable tool for strategic planning, investment decisions, and resource allocation. 

portfolio optimization featured image

Epidemiology forecasting and the impact of data sources on accuracy

The relationship between epidemiology forecasting and data sources is a complex one. Generating accurate forecasts relies heavily on data, and factors such as real-world data and artificial intelligence (AI) have an increasing impact.